Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 9 March 2007:
Vol. 315. no. 5817, p. 1351
DOI: 10.1126/science.315.5817.1351b
Prev | Table of Contents | Next

ScienceScope

The already well-heeled Broad Institute in Cambridge, Massachusetts, this week announced a $100 million gift from a wealthy direct marketer to conduct research on severe mental illnesses such as bipolar disorder and schizophrenia. The funding from the Stanley Medical Research Institute will allow the Broad--a joint venture between the Massachusetts Institute of Technology and Harvard University--to create an interdisciplinary center that will draw on the universities' expertise in neuroscience and genomics. That center, located within the Broad Institute, will be led by Edward Scolnick, a former National Institutes of Health researcher and president of Merck Research Laboratories. The money from the Stanley Institute, founded by the family of Theodore and Vada Stanley, will help Broad researchers apply "the most advanced genomic tools" to the biology of mental illness, says Harvard Provost Steven Hyman.




To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)